| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2007;38:2506.)
© 2007 American Heart Association, Inc.
Original Contributions |
From Service de Neurologie (K.V., A.K., M.-G.B.), Unité de Recherche Clinique (E.V., C.B.), Département dAnesthésie Réanimation et Réanimation Chirurgicale (J.M., D.P.), Service de Neurochirurgie (M.O., A.C., B.G.), and Service de Neuroradiologie (J.-P.G.), Assistance Publique–Hôpitaux de Paris, Hôpital Lariboisière, Paris; Service de Neurologie (G.C.), Centre Hospitalier Universitaire de Dijon, Dijon; Service de Neurologie (F.R.), Centre Hospitalier Universitaire de Bordeaux, Bordeaux; Service de Neurologie (E.T.), Centre Hospitalier Sainte-Anne, Paris; Service de Neurologie (B.G.), Centre Hospitalier Universitaire de Nantes, Nantes; and Service de Rééducation et de Réadaptation Fonctionnelles (A.Y.), Assistance Publique–Hôpitaux de Paris, Hôpital Fernand–Widal, Paris, France.
Correspondence to Katayoun Vahedi, MD, Assistance Publique–Hôpitaux de Paris, Hôpital Lariboisière, Service de Neurologie, 2 rue Ambroise Paré, 75010 Paris, France. E-mail katayoun.vahedi{at}lrb.aphp.fr
Background and Purpose— There is no effective medical treatment of malignant middle cerebral artery (MCA) infarction. The purpose of this clinical trial was to assess the efficacy of early decompressive craniectomy in patients with malignant MCA infarction.
Methods— We conducted in France a multicenter, randomized trial involving patients between 18 and 55 years of age with malignant MCA infarction to compare functional outcomes with or without decompressive craniectomy. A sequential, single-blind, triangular design was used to compare the rate of development of moderate disability (modified Rankin scale score
3) at 6 months follow-up (primary outcome) between the 2 treatment groups.
Results— After randomization of 38 patients, the data safety monitoring committee recommended stopping the trial because of slow recruitment and organizing a pooled analysis of individual data from this trial and the 2 other ongoing European trials of decompressive craniectomy in malignant MCA infarction. Among the 38 patients randomized, the proportion of patients with a modified Rankin scale score
3 at the 6-month and 1-year follow-up was 25% and 50%, respectively, in the surgery group compared with 5.6% and 22.2%, respectively, in the no-surgery group (P=0.18 and P=0.10, respectively). There was a 52.8% absolute reduction of death after craniectomy compared with medical therapy only (P<0.0001).
Conclusions— In this trial, early decompressive craniectomy increased by more than half the number of patients with moderate disability and very significantly reduced (by more than half) the mortality rate compared with that after medical therapy.
Key Words: clinical trials craniectomy middle cerebral artery
Related Article:
Stroke 2007 38: 2410-2412.
This article has been cited by other articles:
![]() |
V. Ramaswamy, V. Mehta, M. Bauman, L. Richer, P. Massicotte, and J. Y. Yager Decompressive Hemicraniectomy in Children With Severe Ischemic Stroke and Life-Threatening Cerebral Edema J Child Neurol, August 1, 2008; 23(8): 889 - 894. [Abstract] [PDF] |
||||
![]() |
R. A. Fowler, N. K. J. Adhikari, D. C. Scales, W. L. Lee, and G. D. Rubenfeld Update in Critical Care 2007 Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 808 - 819. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |